硫化:其双捐体和混合药物的近期发展
Shi Xu1, Meg Shieh1, Bindu D Paul2,3,4,5
1Department of Chemistry, Brown University, Providence, Rhode Island, USA.
British journal of pharmacology
|August 9, 2023
概括
硫化 (H2S) 双重供体通过与其他分子共同提供H2S提供增强的治疗潜力. 这种创新方法旨在提高治疗效率,减少各种疾病的副作用.
科学领域:
- 生物化学和分子生物学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 硫化 (H2S) 是一个关键的气体递质,调节细胞氧化还原恒温.
- 对于心血管和神经退行性疾病,H2S的治疗应用得到了认可.
- 现有的释放H2S的化合物主要是单一地释放H2S.
研究的目的:
- 审查最近在开发基于H2S的双捐体和混合药物的进展.
- 探索这些新型化合物的设计原理和协同效应.
- 突出联合交付系统在治疗应用中的潜力.
主要方法:
- 关于H2S双捐体和混合药物的科学出版物的文献综述.
- 分析设计策略,以与其他治疗剂共同提供H2S.
- 评估报告的协同效应和减轻副作用的可能性.
主要成果:
- 新兴的化合物开发与反应性氧/物种 (ROS/RNS) 共同交付H2S.
- 双重捐赠者在抵消单一治疗的负面影响方面表现有前途.
- 观察到协同效应,可能导致提高临床疗效.
结论:
- 基于H2S的双捐体和混合药物代表了药物开发的重大进步.
- 这些化合物提供了一个比单个捐赠者更生理相关的方法.
- 对设计和应用的进一步研究有可能改善治疗结果.
相关概念视频
Preparation and Reactions of Sulfides
4.9K
Sulfides are the sulfur analog of ethers, just as thiols are the sulfur analog of alcohol. Like ethers, sulfides also consist of two hydrocarbon groups bonded to the central sulfur atom. Depending upon the type of groups present, sulfides can be symmetrical or asymmetrical. Symmetrical sulfides can be prepared via an SN2 reaction between 2 equivalents of an alkyl halide and one equivalent of sodium sulfide.
4.9K
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
3.4K
Catalytic hydrogenation of alkenes is a transition-metal catalyzed reduction of the double bond using molecular hydrogen to give alkanes. The mode of hydrogen addition follows syn stereochemistry.
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
3.4K
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
289
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
289
Preparation and Reactions of Thiols
6.3K
Thiols are prepared using the hydrosulfide anion as a nucleophile in a nucleophilic substitution reaction with alkyl halides. For instance, bromobutane reacts with sodium hydrosulfide to give butanethiol.
6.3K


